Has Daniel Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $227,220 in general payments to Daniel Patel, MD across 246 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Patel, MD

Nephrology · Daytona Beach, FLNPI 1669683769

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. W. L. Gore & Associates, Inc. accounts for 79.0% of it on its own, with 12 other manufacturers making up the rest. Among nephrology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$227,220in general payments, 2019–2025

Across 246 payments — averaging $923.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

W. L. Gore & Associates, Inc.$179K
Philips North America LLC$31K
Medtronic$8K
Merit Medical Systems Inc$7K
Bard Peripheral Vascular, Inc.$545
AstraZeneca$220
plus $651 from 7 others

$75,400in research payments, 2019–2025

Across 82 payments — averaging $919.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$75K

What the payments were for

Consulting fees$121,61054%
Speaking & faculty fees$74,32333%
Travel & lodging$24,27311%
Food & beverage$6,9133%
Education$1000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
W. L. Gore & Associates, Inc.	189	$179,411
Philips North America LLC	13	$30,869
Medtronic(2 entities)	22	$8,138
Merit Medical Systems Inc	10	$7,386
Bard Peripheral Vascular, Inc.	2	$545
AstraZeneca	2	$220
Covidien LP	1	$131
Inari Medical, Inc.	1	$117
Cook Medical LLC	2	$113
Mallinckrodt Hospital Products Inc.	1	$103
Regeneron	1	$100
Veloxis Pharmaceuticals, Inc.	1	$54
Cormedix Inc.	1	$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$66,460
GORE VIABAHN Endoprosthesis with Heparin$50,550
GORE VIABAHN Endoprosthesis$37,854
VIABAHN Endoprosthesis$27,244
ACUSEAL Vascular Graft$18,652
IGT D Peripheral$14,100
(9520) IGT Devices Undivided$7,620
Product in Development$6,450
Wrapsody Stent Graft$6,122
IN.PACT Admiral$5,592
Spectranetics Undiv$5,453
GORE ACUSEAL Vascular Graft$3,937
EXCLUDER AAA Endoprosthesis$3,900
IVUS Systems$3,600
GORE PROPATEN Vascular Graft$3,360
IN.PACT AV$1,625
VIATORR TIPS Endoprosthesis$1,560
WRAPSODY Endovascular Stent Graft System$350
ELLIPSYS VASCULAR ACCESS SYSTEM$347
GORE EXCLUDER AAA Endoprosthesis$173

How this compares

$227,220 in reported general payments places this provider in the 95th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida →

Medicare billing

Part B allowed, 2024

$1,070,691

Medicare patients

348

Services billed

5,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisone	31	$62

Paid to pharmacies, not to this prescriber.

Other nephrology in Daytona Beach

Arvind MadanOrlando$943K
John CopleyWeston$934K
Jorge LarranagaKissimmee$825K
Carlos BejarFort Lauderdale$530K
Wayne KotzkerFort Lauderdale$472K
Jason RothschildTemple Terrace$413K
Rafael Baez BonillaFort Lauderdale$175K
Gabriel ContrerasMiami$133K
Fouad ChebibJacksonville$122K
Jeremy CarlsonJacksonville$105K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →